Skip to main content
IRWD
NASDAQ Life Sciences

Ironwood's LINZESS Gains FDA Approval for Pediatric Functional Constipation

Tom Rudovsky · Reported by dpa-AFX
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$3.55
Mkt Cap
$584.378M
52W Low
$0.562
52W High
$5.78
52W Position info
532% above low
Off High info
39% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

IRWD has more than doubled off its 52-week low of $0.562 on light trading volume (0.2× avg).

Summary

Ironwood Pharmaceuticals secured FDA approval for LINZESS to treat functional constipation in children aged 2-5, expanding its key product's market to a new pediatric population. This approval for a new 72-mcg pediatric dose is a significant positive development, broadening the LINZESS franchise. The article also mentions a label expansion for Johnson & Johnson's TREMFYA, but this news was already reported yesterday.

At the time of this announcement, IRWD was trading at $3.55 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $584.4M. The 52-week trading range was $0.56 to $5.78. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: dpa-AFX.


Price Chart

Share this article

Copied!

IRWD - Latest Insights

IRWD
Nov 05, 2026, 4:06 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $4.04
Real-time Price: $3.99 info
Change: -$0.050 (-1%) info
Market Cap: $665.917M info
IRWD
Nov 05, 2026, 7:54 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $4.14
Real-time Price: $3.99 info
Change: -$0.145 (-4%) info
Market Cap: $665.917M info
IRWD
Nov 05, 2026, 7:05 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.25
Real-time Price: $3.99 info
Change: -$0.260 (-6%) info
Market Cap: $665.917M info
IRWD
Nov 05, 2026, 7:05 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $3.78
Real-time Price: $3.99 info
Change: +$0.210 (+6%) info
Market Cap: $665.917M info
IRWD
Oct 16, 2026, 7:30 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.78
Real-time Price: $3.99 info
Change: +$0.210 (+6%) info
Market Cap: $665.917M info